Literature DB >> 3048486

Cytokines as mediators of graft-versus-host disease.

J Cohen1.   

Abstract

Cytokines are proteins produced mainly by lymphocytes in response to an antigenic stimulus. Originally identified and named on the basis of their biological activity, they are now called interleukins; together with the interferons, colony-stimulating factors and tumour necrosis factor/cachectin (TNF) they form a complex and overlapping network of communication between immunocompetent cells. Cytokines play a central role in T cell activation, and interleukin 2 and interferon gamma in particular are involved in the expression of graft-versus-host disease after bone marrow transplantation. Recent studies suggest that TNF is also implicated: the gene encoding TNF is situated close to the MHC gene in both mice and humans, and TNF is able to up-regulate constitutively expressed class II antigen and, with interferon gamma, to induce class II expression in previously normal cells. Bacterial lipopolysaccharide (endotoxin) is a powerful stimulus to TNF, and TNF production may be the mechanism underlying the longstanding observations on the role of the bacterial microflora of the gut in graft-versus-host disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048486

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Graft versus leukemia.

Authors:  A Butturini; R P Gale
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Authors:  H Walczak; M A Degli-Esposti; R S Johnson; P J Smolak; J Y Waugh; N Boiani; M S Timour; M J Gerhart; K A Schooley; C A Smith; R G Goodwin; C T Rauch
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 3.  Tumor necrosis factor: an update on basic research and clinical applications.

Authors:  M Schleuning; R Munker
Journal:  Klin Wochenschr       Date:  1990-09-03

4.  Sequential measurement of the murine acute-phase protein serum amyloid P component (SAP) as an indicator of graft-versus-host disease following allogeneic bone marrow transplantation in mice.

Authors:  K F Bayston; R Huby; J Cohen
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

5.  Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.

Authors:  G F Murphy; D Whitaker; J Sprent; R Korngold
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  Antigenaemia during acute graft versus host disease.

Authors:  C Fegan; S K Jackson; J A Whittaker
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

7.  Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice.

Authors:  A C Knulst; G J Tibbe; C Bril-Bazuin; E G Breedland; A van Oudenaren; R Benner; H F Savelkoul
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.